Detalhe da pesquisa
1.
SOLTI-1904 ACROPOLI TRIAL: efficacy of spartalizumab monotherapy across tumor-types expressing high levels of PD1 mRNA.
Future Oncol
; 2022 Oct 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36200668
2.
SOLTI-1503 PROMETEO TRIAL: combination of talimogene laherparepvec with atezolizumab in early breast cancer.
Future Oncol
; 16(24): 1801-1813, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32633563
3.
Oral metronomic vinorelbine combined with endocrine therapy in hormone receptor-positive HER2-negative breast cancer: SOLTI-1501 VENTANA window of opportunity trial.
Breast Cancer Res
; 21(1): 108, 2019 09 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-31533777
4.
Safety, activity, and molecular heterogeneity following neoadjuvant non-pegylated liposomal doxorubicin, paclitaxel, trastuzumab, and pertuzumab in HER2-positive breast cancer (Opti-HER HEART): an open-label, single-group, multicenter, phase 2 trial.
BMC Med
; 17(1): 8, 2019 01 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30621698
5.
HOPE (SOLTI-1903) breast cancer study: real-world, patient-centric, clinical practice study to assess the impact of genomic data on next treatment decision-choice in patients with locally advanced or metastatic breast cancer.
Front Oncol
; 13: 1151496, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37188177
6.
Oncolytic viruses: A new immunotherapeutic approach for breast cancer treatment?
Cancer Treat Rev
; 106: 102392, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35436729
7.
Neoadjuvant eribulin in HER2-negative early-stage breast cancer (SOLTI-1007-NeoEribulin): a multicenter, two-cohort, non-randomized phase II trial.
NPJ Breast Cancer
; 7(1): 145, 2021 Nov 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34824288
8.
First Nationwide Molecular Screening Program in Spain for Patients With Advanced Breast Cancer: Results From the AGATA SOLTI-1301 Study.
Front Oncol
; 11: 744112, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34804931
9.
Palbociclib and Trastuzumab in HER2-Positive Advanced Breast Cancer: Results from the Phase II SOLTI-1303 PATRICIA Trial.
Clin Cancer Res
; 26(22): 5820-5829, 2020 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32938620
10.
Dynamics and dispensability of variant-specific histone H1 Lys-26/Ser-27 and Thr-165 post-translational modifications.
FEBS Lett
; 588(14): 2353-62, 2014 Jun 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-24873882